Intermediate- versus prophylactic-dose heparin for hospitalised patients with COVID-19: an updated meta-analysis of randomised trials.
Saved in:
| Title: | Intermediate- versus prophylactic-dose heparin for hospitalised patients with COVID-19: an updated meta-analysis of randomised trials. |
|---|---|
| Authors: | Godolphin PJ; UCL Innovative Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK. p.godolphin@ucl.ac.uk., Fisher DJ; UCL Innovative Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Bradbury CA; University of Bristol, Bristol, UK., Murthy S; University of British Columbia, Vancouver, Canada., Vale CL; UCL Innovative Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK. |
| Source: | Intensive care medicine [Intensive Care Med] 2026 Apr; Vol. 52 (4), pp. 800-802. Date of Electronic Publication: 2026 Apr 07. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Springer Verlag Country of Publication: United States NLM ID: 7704851 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1238 (Electronic) Linking ISSN: 03424642 NLM ISO Abbreviation: Intensive Care Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1432-1238 |
|---|---|
| DOI: | 10.1007/s00134-025-08128-0 |
